Home>News> GlaxoSmithKline’s job whacking touches U.S. consumer plant

GlaxoSmithKline’s job whacking touches U.S. consumer plant

A GlaxoSmithKline consumer health products plant in Tennessee has had its ups and downs. Currently, it is having a down. The U.K.-based drugmaker will lay off nearly 100 employees at the facility in Memphis.
 
GSK last week notified (PDF) state authorities in a WARN notice that it will begin phased layoffs of 99 workers Dec. 10, which it said is slated to be completed by April 2. The job cutting is the result of GSK losing a contract manufacturing agreement, which will end in January, spokesperson Caryn Previdi said in an email.

Tags: